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ABSTRACT
To investigate the relationship between local respon-
siveness and allergic symptoms, bronchial and nasal
responsiveness were measured in the following four
groups of subjects: (i) bronchial asthma patients with
serum house dust mite (HOM)-specific IgE antibody; (ii)
allergic rhinitis patients with serum HOM-specific IgE
antibody; (iii) normal control subjects with HOM-specific
IgE antibody; and (iv) normal control subjects without
IgE antibody specific for 10 common aero-allergens.
Bronchial hyperresponsiveness was detected in all
subjects with asthma (group 1) and in some subjects
from groups 2 and 3, but not in subjects from group 4.
Nasal hyperresponsiveness was found in all subjects
with allergic rhinitis (group 2) and in some subjects from
groups 1 and 3, but not in subjects from group 4. These
findings indicate that local hyperresponsiveness of the
non-diseased organ is influenced by an individual's
atopic status. Interleukin (IL)-4 and IL-5 production by
peripheral blood mononuclear cells (PBMC) was
measured after stimulation with HOM in groups 1, 2
and 3 and was found to be similar in all three groups. A
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correlation between bronchial hyperresponsiveness and
in vitro cytokine production was noted in asthma
patients. These results suggest that the capacity of IL-4
or IL-5 production by PBMC may reflect local hyper-
responsiveness in case of asthma.
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INTRODUCTION
Bronchial asthma (BA) is a disease characterized by
increased bronchial reactivity.1 Patients with perennial
rhinitis have a hyperreactive nasal mucosa (nasal
hyperreactivity).2,3 It has been suggested that allergic
rhinitis patients who have bronchial hyperresponsiveness
are more likely to develop asthma. 4,s In contrast, it has
not been clearly determined whether BA patients have
nasal hyperreactivity, despite the strong epidemiologic
associations between atopic asthma and allergic rhinitis."
Although increased airway responsiveness has been
reported in patients with allergic rhinitis who show no
asthma syrnptorns.v' it is not clear whether the associ-
ation is predominantly with rhinitis itself or with the atopic
status of the rhinitis patients.
Of all potential allergens in the environment associ-
ated with asthma, allergy to house dust mite (HOM) is the
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most common independent risk factor for the develop-
ment of the disecse." It is also known that HOM is a
significant perennial indoor allergen that can precipitate
allergic rhinitis." In the present study we used serum IgE
antibody titer to HOM to evaluate atopic status.
To investigate the association between local respon-
siveness and allergic symptoms among individuals with
serum HOM-specific IgE antibody, we studied four groups
of patients and normal subjects. Our purpose was to
determine how local responsiveness (bronchial or nasal)
and cytokine production from peripheral blood mono-
nuclear cels (PBMC) influenced the occurrence of BA and
allergic rhinitis.
METHODS
Subjects
Subjects with the following characteristics were chosen
randomly from our clinics (Internal Medicine and
Otolaryngology, Osaka Teishin Hospital and Osaka
University Medical School, Osaka, Japan) and
volunteers: (i) patients with a clinical diagnosis of BA
who had no history of allergic rhinitis and had elevated
serum levels of HOM-specific IgE antibody (n = 13);
(ii) patients with a clinical diagnosis of allergic rhinitis
who had no history of asthma and had elevated serum
levels of HOM-specific IgE antibody (n = 11); (iii)
volunteers working at our hospital with no history of
asthma or allergic rhinitis who had elevated serum
Table 1. Clinical characteristics of subjects
---
levels of HOM-specific IgE antibody (n = 10); and (iv)
volunteers working at our hospital with no specific IgE
antibody for the following 10 aero-allergens (n = 9):
Dermatophagoides pteronyssinus (Der p), Dermato-
phagoides farinae (Der ~, house dust 1, house dust 2,
ragweed pollen, orchard grass, Aspergillus fumigatus,
Candida albicans, Alternaria alternata and Japanese
cedar pollen. The clinical characteristics of the subjects
are shown in Table 1. Specific IgE antibodies were
measured with a Pharmacia CAP System (Pharmacia,
Uppsala, Sweden) by external commercial labora-
tories. A CAP-RAST class of 2 or more was considered
positive (class 0, < 0.34 UA/mL; class 1, 0.35-0.69
UA/mL; class 2, 0.7-3.4 UA/mL; class 3, 3.5-17.4
UA/mL; class 4, 17.5-49.9 UA/mL; class 5, 50.0-
99.9 UA/mL; class 6, > 100 UA/mL). House dust mite
was Der f in both the CAP-RAST assay and in the in vitro
studies. Forced vital capacity and forced expiratory
volume in 1 s were measured using a spirometer
(Autospiro AS-500; MINATO Ltd, Osaka, Japan).
Bronchial and nasal responsiveness
Bronchial responsiveness was measured with an
Astograph (Chest Corp., Tokyo, Japan, a direct-writing
recorder for respiratory resistance (Rrs) dose-response
curves, during continuous inhalation of methacholine
at stepwise incremental concentrotions.!" Respiratory
resistance was measured by the forced oscillation
method. It showed a curvilinear increase with an increase
~_._._-~_.~_._---- -
Group 1 Group 2 Group 3 Group 4
-------
------_._--~---_._~_.~---
---.--~---
No. subjects 13 11 10 9
Gender (M/F) 6/7 3/8 6/4 5/4
Smoker/non-smoker 2/11 2/9 2/8 3/6
Age (years)* 44.7 (17.9) 34.9 (14.6) 37.0 (15.5) 34.9 (13.5)
CAP-RAST score for 3.31 (1.11) 3.54 (0.93) 3.50 (1.08) 0
HOM (Der~*
Serum IgE level 399 (26-1200) 308 (24-710) 889 (32-4400) 68 (7-200)
(IU/mL)**
Eosinophil count in 513 (200-1500) 314 (0-640) 295 (65-670) 121 (61-240)
peripheral blood (lmm3)**
% FVC* 89.6 (14.0) 95.4 (13.0) 95.6 (7.2) 91.8 (16.1)
FEV1o%* 81.5(13.1) 92.0 (6.3) 91.8 (7.7) 92.5 (5.3)
*Oata are the mean with SO given in parentheses; **data are the mean with the range given in parentheses.
% FVC, %of predicted forced vital capacity; FEV1 0%, % of predicted forced expiratory volume in 1 s; HOM, house dust mite.
Group 1, bronchial asthma patients with serum HOM-specific IgE antibody; group 2, allergic rhinitis patients with serum HOM-specific IgE
antibody; group 3, control subjects with no symptoms of allergic diseases who have serum HOM-specific IgE antibody; group 4, control subjects with
no symptoms of allergic diseases and no specific serum IgE antibody for a panel of 10 aero-allergens, including HOM.
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RESULTS
Fig. 1 Individual values for the minimum dose of
methacholine (Omin) in the four groups, where Omin is an
indicator of bronchial responsiveness and Omin > 50 is normal.
- ..
Bronchial responsiveness
All 13 asthma patients (group 1) showed bronchial
hyperresponsiveness (Dmin < 50; Fig. 1). Three of 11
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these assays, 0.1-1000 pg/mL IL-4 or 2-1 000 pg/mL IL-
5 was measured in the supernatants and was compared
with different concentrations of recombinant IL-4 or IL-5.
Interleukin-4 and -5 production was measured within 6
weeks after the assessment of bronchial and nasal
responsiveness.
Statistical analysis
The Student's t-test and the Mann-Whitney U-test were
used for comparisons between groups. Correlations were
investigated using Spearman's rank correlation test.
Reagents and cells
RPMI 1640 (Gibco, Grand Island, NY, USA), supple-
mented with 10% fetal bovine serum (FBS; Gibco), 2-
mercaptoethanol (0.05 mmollL), penicillin (100 U/mL)
and streptomycin (0.1 mg/mL), was used as the culture
medium. House dust mite (Der ~ extract was provided by
Torii Co. Ltd (Tokyo, Japan).
in the methacholine concentration. The minimum dose of
methacholine (Dmin) was used as an indicator of bronchial
sensitivity and was defined as the cumulative dose at the
inflection point where the reciprocal of Rrs (Grs)
decreased linearly; Dmin was expressed in units equal to a
1.0 mg/mL aerosol inhalation of methacholine for 1 min.
The existence of bronchial hyperresponsiveness was
determined by a Dmin value < 50. 10 Drugs were dis-
continued at least 12 h before the study. Nasal
responsiveness was measured by placing a piece of
round paper (Toyo-Roshi No.5, Tokyo, Japan)
containing increasing doses of histamine chloride over
the surface of the inferior turbinate bilctercllv. ' The
logarithm of the histamine chloride concentration that
induced sneezing and nasal secretion was defined as
nasal responsiveness. Histamine chloride was prepared
at concentrations ranging from 105 to 10 uq/rnl, by serial
la-fold dilution. Bronchial responsiveness and nasal
responsiveness were measured on separate days (1-2
weeks apart). All subjects were free from wheezing,
cough, nasal discharge, sneezing and respiratory tract
infection for at least 3 weeks before the test. Fully
informed consent was obtained from all subjects
participating before entry into the study.
Measurement of interleukin-4 and -5
production
Peripheral blood mononuclear cells were isolated from
heparinized venous blood by density gradient centrifuga-
tion on Ficoll-Hypaque (Pharmacia, Uppsala, Sweden).
Isolated mononuclear cells (2 X 106 /mL) were added
to each well of a 24-well culture plate in 0.5 mL culture
medium with mite extract (10 uq/ml}, which was the
optimal concentration for interleukin (IL)-4 svnthesis.!'
After 48 h, the supernatant was collected and the amount
of IL-4 and IL-5 was measured by ELISA (Compact
Interleukin 4 ELISA kit; CLB, Amsterdam, The Nether-
lands; ELISA for human Interleukin 5; Immunotech
International, Marseilles, France, respectively). Using
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rhinitis patients (group 2) and three of 10 HOM-specific
IgE positive normal control subjects (group 3) also
showed bronchial hyperresponsiveness. Overall, 55.9%
of subjects with elevated levels of HOM-specific IgE
showed bronchial hyperresponsiveness. In contrast,
none of the nine normal control subjects without
specific IgE (group 4) showed bronchial hyper-
responsiveness.
Nasal responsiveness
In a preliminary study, normal individuals without a history
of rhinitis showed a nasal responsiveness of 4 or 5. Most
normal control subjects without specific IgE (7/9; group 4)
also showed a nasal responsiveness of 4 or 5 (Fig. 2).
Seven of 13 BA patients (group 1) and eight of 10 HOM-
specific IgE positive normal control subjects (group 3)
showed nasal hyperresponsiveness (score ~ 3). All 11
rhinitis patients (group 2) showed nasal hyperresponsive-
ness and it was more prominent than in the other three
groups. Overall, 76.4% of subjects with elevated levels of
HOM-specific IgE showed nasal hyperresponsiveness.
Interleukin-4 and -5 production from PBMC
Peripheral blood mononuclear cells from subjects in
groups 1-3 were stimulated with HOM extract in vitro and
the IL-4 and -5 levels in culture supernatants were
10
--' 8E
<,
0)
CL
c 6
0
U
=> •\J 4 •2 •
CL •
""<:/'
~ 2
-
,
....!... ....... ....L.
•
•
•
0
-
Group 1 Group 2 Group 3
Asthma Rh initis Control
HDM l+l
5 -
- -
Fig. 3 Interleukin (IL)-4 production by peripheral blood cells
stimulated with house dust mite. Mean values, expressed as the
geometric mean, are represented by horizontal bars.
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Fig. 4 Interleukin (IL)-5 production by peripheral blood
Fig. 2 Individual nasal responsiveness to histamine chloride mononuclear cells stimulated with house dust mite. Geometric
in the four groups. A nasal responsiveness of 4 or 5 is normal. mean values are represented by horizontal bars.
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subjects in each of the groups 1-3 or among all subjects
in these three groups combined. However, the
relationship between Omin (bronchial responsiveness) and
IL-4 production in asthma patients (group 1) showed a
strong negative correlation (Fig. 50; r = -0.79; P
< 0.01), although no such correlation was found among
all subjects who had bronchial hyperresponsiveness (Omin
< 50) in groups 1-3. The relationship between Omin and
IL-5 production in asthma patients showed a weaker
negative correlation (Fig. 5b; r = -0.51; P = 0.07),
while IL-5 and bronchial responsiveness showed no
relationship among all subjects with bronchial
hyperresponsiveness (Omin < 50) in groups 1-3. The
relationship between Omin and cytokine production could
not be assessed separately in groups 2 or 3 because only
three subjects showed bronchial hyperresponsiveness in
each group. There was a strong positive correlation
between IL-4 and -5 production in BA patients (r = 0.66;
P < 0.03; data not shown).
DISCUSSION
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Fig. 5 (a) Relationship between interleukin (IL)-4 and the
minimum dose of methacholine (Omin) in bronchial asthma
(group 1). There is a significant negative correlation
(r = -0.79; P < 0.01). (b) Relationship between IL-5 and Omin
in bronchial asthma patients (group 1). There is a weak
negative correlation (r = 0.51; P = 0.07).
measured (Figs 3,4). The mean IL-4 levels were 1.5 ±
1.8,1.8 ± 1.9 and 1.7 ± 2.1 pg/mL in groups 1,2 and
3, respectively, while the respective IL-5 levels were found
to be 64 ± 65, 106 ± 54 and 75 ± 81 pg/mL. There
was no significant difference in the production of either
cytokine among the different groups with HOM-specific
IgE positivity.
Local responsiveness and cytokine production
To test whether local responsiveness (bronchial and nasal
responsiveness) may be influenced by cytokine pro-
duction in peripheral blood, the relationship between
local responsiveness and IL-4 or -5 production was
investigated. There was no correlation between nasal
responsiveness and IL-4 or -5 production among the
The results of the present study suggest an association
between atopy and local hyperresponsiveness. Of the
subjects with an elevated serum level of HOM-specific
IgE, all asthma patients (group 1) had bronchial hyper-
responsiveness (Omin < 50). In addition, approximately
30% of both allergic rhinitis patients (group 2) and
subjects with no allergic symptoms (group 3) had
bronchial hyperresponsiveness. In contrast, the normal
control subjects with no aero-allergen-specific IgE (group
4) did not have bronchial hyperresponsiveness. Similar
results were obtained in the case of nasal responsiveness.
Of the subjects with elevated serum HOM-specific IgE, all
rhinitis patients (group 2) had nasal hyperresponsiveness
and more than half of both groups 1 and 3 also had
moderate nasal hyperresponsiveness. Most normal
control subjects with no aero-allergen-specific IgE had
normal nasal responsiveness. Witt et 0/. have reported
that the prevalence of bronchial histamime respon-
siveness in adults increased from 5.8% in subjects who
did not respond to allergen prick tests to 22.2% in
subjects who responded to all five allergen qroups.'?
Woolcock et 01. reported that 7.3% of non-atopic
subjects showed bronchial hyperresponsiveness
compared with 16.5% of those with severe atopy, and
stated that there was a significant association between
bronchial responsiveness and atopy in random adult
populotions.':' Our results are compatible with these
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findings and extend the association with atopy to nasal
hyperresponsiveness.
It is well known that allergic rhinitis patients often have
bronchial hvperresponsiveness;"? but whether BA
patients have nasal hyperresponsiveness has been
unclear. In accordance with our clinical experience, more
than half the asthma patients with serum HOM-specific
IgE (group 1) showed nasal hyperresponsiveness in the
present study. This may explain why asthma patients often
complain of nasal symptoms. Although bronchial respon-
siveness showed almost no overlap between asthma
patients and non-atopic normal control subjects, nasal
responsiveness did not completely separate rhinitis
patients from non-atopic normal control subjects. This
may be because nasal responsiveness can be acquired
readily after nasal infection and rhinitis is more common
than asthma. In any event, local responsiveness of the
non-diseased organ was increased to some extent
among serum HOM-specific IgE positive subjects (groups
2 and 3 for bronchial responsiveness and groups 1 and 3
for nasal responsiveness), suggesting that local respon-
siveness of the non-diseased organ may be affected by
an individual's atopic status.
Interleukin-4 is known to be a mast cell growth foetor"
and it also promotes B cell isotype switching to IgE .15
Allergen-induced IgE-dependent mast cell degranulation
may be responsible for acute bronchoconstrictor
responses in atopic csthrnc.l? Interleukin-5 promotes the
differentiation,17 vascular adhesion 18 and in vitro survival
of eosinophils '? and eosinophil infiltration and activation
is known to contribute to chronic bronchial hyper-
reoctivitv." It has also been shown that atopic asthma is
associated with increased expression of mRNA for IL-3,
IL-4, IL-5 and granulocyte-macrophage colony stimu-
lating factor in the bronchi." It has also been reported
that cells expressing mRNA for IL-4 and -5 increase
during the allergen-induced nasal response in allergic
rhinitis. 22 Although increases in IL-4 and IL-5 activity has
been shown in diseased organs (bronchial mucosa or
recovered cells from bronchoalveolar lavage for BA and
nasal mucosa for allergic rhinitis), in vitro cytokine
production by PBMC stimulated with antigen has not
been well characterized in patients with allergic diseases.
Secrist et a/. reported that allergen immunotherapy
decreased IL-4 production by C04 + T cells from allergic
individuols." Ochi et a/. reported that both cultured
lymphocytes and basophils from the peripheral blood of
allergic individuals produced IL-4 in response to
ollerqen.!' In the present study, we evaluated the in vitro
production of IL-4 and -5 by PBMC stimulated with HOM
and found that the levels of these cytokines were similar
among serum HOM-specific IgE-positive subjects (groups
1-3). This finding implies that the amount of these
cytokines produced in vitro is not related to either the
presence or the type of allergic disease.
Next we evaluated the correlation between local
responsiveness and various clinical parameters. No
correlation was found between nasal responsiveness and
the total serum IgE level, the eosinophil count in the
peripheral blood and IL-4 or -5 production by PBMC
stimulated with HOM. Bronchial responsiveness (Omin)
was negatively correlated with IL-4 production by PBMC
among asthma patients (group 1). Although there was a
negative correlation between bronchial responsiveness
and IL-5 production by PBMC among asthma patients, it
was not statistically significant. Bronchial responsiveness
was also not correlated with various clinical parameters,
such as the total serum IgE level or the eosinophil count
in the peripheral blood. We used methacholine for the
assay of bronchial responsiveness and should point out,
however, that the possibility exists that the use of
histamine for bronchial responsiveness may provide a
more significant correlation between bronchial respon-
siveness and cytokine production by PBMC. Robinson et
01. reported a negative correlation between airway
methacholine responsiveness and the number of
bronchoalveolar lavage cells expressing IL-5 mRNA, but
not IL-4 mRNA24 Ackerman et 01. reported that the level
of airway hyperresponsiveness in atopic asthma patients
was negatively correlated with the IL-5 immunoreactivity
of bronchial biopsies, but not with IL-4 immuno-
recctivity" Our results appear to be different from those
of Robinson et a/.24 and Ackerman et a/.25 One reason
may be that we assayed in vitro cytokine production by
PBMC stimulated with antigen, whereas they assayed
either bronchoalveolar lavage cells or bronchial mucosa.
However, the significant negative correlation between
bronchial hyperresponsiveness and IL-4 production, as
well as the weaker negative correlation between
bronchial hyperresponsiveness and IL-5 production in
our asthma patients, supports the notion that the capacity
of cytokine production by PBMC may reflect bronchial
responsiveness among asthmatic patients.
Finally, there were two non-asthmatic subjects who had
bronchial hyperresponsiveness in the asthmatic range,
atopic status (an HOM CAP-RAST score ~ 3) and an
above average production of both IL-4 and -5 by
peripheral blood (one in the allergic rhinitis group and
one with no allergic symptoms). The reason why these
subjects did not develop asthma symptoms is unclear and
the additional factors necessary to provoke overt
symptoms of asthma need to be defined in the future.
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